Human Fibrinogen Concentrate Market (Type: 0.5g, 1.0g, Others; Application: Congenital Fibrinogen Deficiency, Surgical Procedures) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2025

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 132

Introduction

Fibrinogen additionally called as factor I is a protein delivered by liver which helps in thickening of blood. The solvent fibrinogen in blood plasma is separated in fibrins by thrombin chemical which results in blood clump. Lower fibrinogen fixation prompts massive bleeding, and may cause thrombosis. Thrombosis includes development of blood clumps inside the vein which blocks blood stream. Thrombosis may have genuine entanglements if blockage is found in basic territories and prompts heart assault or stroke. Diminished dimension of fibrinogen results in ceaseless liver ailment, expansive volume blood transfusion and serious ailing health; while lifted dimensions cause rritation, tissue harm, certain malignancies, stroke, and extreme contaminations and therefore the test has a wide application in ailment determination. Fibrinogen inadequacy may emerge because of hereditary legacy of an inadequate DNA. These hereditary issues incorporate afibrinogenemia which is related with nonexistence of fibrinogen, hypofibrinogenemia related with lower than ordinary level, dysfibrinogenemia which includes improper working of the protein. The fibrinogen atom is a solvent, substantial, and complex 340 kDa plasma glycoprotein that is changed over by thrombin into fibrin amid blood clump arrangement. It has a pole like shape with measurements of 9 × 47.5 × 6 nm and it demonstrates a negative net charge at physiological pH (IP at pH 5.2). Fibrinogen is blended in the liver by the hepatocytes. The centralization of fibrinogen in the blood plasma is 200– 400 mg/dL (regularly estimated utilizing the Clauss strategy.

Market Dynamics

The market will be driven by expanding occurrences where fibrinogen tests are advised; these include stroke, liver sicknesses, hemophilia, incendiary maladies, and others. As indicated by National Hemophilia Foundation, New York, U.S., factor I inadequacy which incorporates afibrinogenemia, dysfibrinogenemia, or hypofibrinogenemia has occurrences in 2 people for each million in the U.S. Conversely, liver malignant growth additionally builds the danger of hemostasis, as it delivers a large portion of coagulating components and inhibitors; in addition it likewise creates different proteins associated with fibrinolysis. In 2012, it has been evaluated that around 120,000 individuals were experiencing liver malignancy and the number was predicted to rise exponentially. This exponential growth of liver disease will likewise play a vital role in development of human fibrinogen concentrate market. However, certain adverse conditions namely dyspnea, arterial thrombosis, vomiting, chills, nausea, and pulmonary embolism curb the market growth. In general diagnostics industry is driven by a major provider and merchant network over the globe. This has helped in huge market penetration of fibrinogen tests, particularly in underdeveloped and developed economics where the predominance of a few ailments, such as, malignant growth and some others are high. The fibrinogen test is projected to become more cost efficient in the light of creating innovation, and expanding a number of neighborhood players in the diagnostics market.

Among human fibrinogen concentrate applications, congenital fibrinogen deficiency portion held most astounding piece of the overall industry in 2017 as far as income and volume are concerned. Growing prevalence of afibrinogenemia is estimated at 1/1,000,000. Hypo- and dysfibrinogenemia are more frequent. Both males and females are equally affected. Fibrinogen insufficiency can be found at any age however afibrinogenemia for the most part shows right off the bat in youth, regularly in the neonatal period. Fibrinogen concentrates are typically utilized for the treatment of hemorrhages. Crisp solidified plasma is utilized when fibrinogen concentrates are not available. Intermittent unconstrained premature births can be forestalled by routine prophylaxis dependent on organization of fibrinogen gathers in early pregnancy. Consequently, holding the major market share and is anticipated to maintain its dominance over the coming years.

Report coverage

Market

Global Human Fibrinogen Concentrates Market

Analysis Period

2013-2025

Base Year

2017

Forecast Data

2018 – 2025

Market Stratification

Type, Application, Geography

Regional Scope

North America, China, Europe, Japan, India, Southeast Asia, Rest of the World

Report Coverage

Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

 

The market research study on “Human Fibrinogen Concentrate Market (Type: 0.5g, 1.0g, Others; Application: Congenital Fibrinogen Deficiency, Surgical Procedures) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2025” offers a detailed insights on the global human fibrinogen concentrates market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global human fibrinogen concentrates market, its type, application, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global human fibrinogen concentrates market size and volume, and segment markets by type, application, and geography along with the information on companies operating in the market. The human fibrinogen concentrates market analysis is provided for major regional markets including North America, China, Europe, Japan, India, and Southeast Asia. For each region, the market size and volume for different segments has been covered under the scope of report. The players profiled in the report include CSL Behring, LFB Group, Shanghai RAAS, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, Greencross, Shanghai XinXing Medical, Boya among others.

The global Human Fibrinogen Concentrate market is segmented as below:

Market Segmentation

Market By Type

  • 0.5g
  • 1.0g
  • Other

Market By Application        

  • Congenital Fibrinogen Deficiency
  • Surgical Procedures  

Market By Geography

  • North America
  • China
  • Europe
  • Japan
  • India
  • Southeast Asia
  • Rest of the World


Related Reports

Botulinum Toxin Market (By Product: Botulinum Toxin Type B, Botulinum Toxin Type A; By End Use: Therapeutics, Aesthetic) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

According to Acumen Research and Consulting, the global Botulinum Toxin market is expected to grow at noteworthy CAGR around 8 % throughout the forecast period and reach around US$ 7.5 billion by 2026. The imperative quality needs and fresh apps are sustaining competition in the worldwide industry of botulinum toxins. Most businesses invest in studies to identify fresh apps which c

Surgical Instrument Tracking Systems Market (By Product: Services, Software, Hardware; By Technology: RFID, Barcodes; By End Use: Hospitals, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global market of Surgical Instrument Tracking Systems is expected to grow at noteworthy CAGR around 18.6 % throughout the forecast period and reach around US$ 500 million by 2026. Surgical instruments have long been accessible for use in healthcare. Systems for the mo

Aesthetic Medicine Market (By Product: Implants, Anti-wrinkle Products [Dermal Fillers, Botulinum Toxin, Chemical Peel], Energy-based Devices [Aesthetic Laser Devices, Microdermabrasion Devices, Ultrasound Devices, Body Contouring Devices]; By End Use: Home Use, Clinics and Beauty Centers) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Aesthetic Medicine market is expected to grow at noteworthy CAGR around 8.5 % throughout the forecast period and reach around US$ 16.3 billion by 2026. Aesthetic Medicines is a clinical subspecialty and field for scientific research that includes all kinds of m

Viscosupplementation Market (By Application: Single Injection, Three Injection, Five Injection) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: Viscosupplementation is a treatment that aids in diminishing joint agony and improves the practical state of the osteoarthritic joint. It includes the infusion of a thick liquid called hyaluronate into the knee. Hyaluronic corrosive is found in the gooey synovial liquid that greased up the ligament surfaces and shields the joint from stun. This corrosive is a versatil

Smart Home Healthcare Market (By Technology: Wired, Wireless; By Service: Installation and Repair, Renovation and Customization; By Application: Safety and Security Monitoring, Memory Aids, Nutrition or Diet Monitoring, Fall Prevention and Detection, Health Status Monitoring, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: Smart home healthcare is intended to help in treatment determination, care in the home. It helps in improving the correspondence between the parental figures and healthcare suppliers. Also, numerous wellbeing conditions, particularly incessant illnesses, could be checked and treated in a home outfitted with fundamental smart home items. The global smar

Hyaluronic Acid Market (By Application: Dermal Fillers, Osteoarthritis [Single Injection, Three Injection, Five Injection], Ophthalmic, Vesicoureteral Reflux) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: The global hyaluronic acid market size is expected to reach 11.07 billion by the end of year 2026. The market is estimated to grow at a CAGR of 6.6% over the forecast period 2019 to 2026. Hyaluronic acid, otherwise called hyaluronan, is a reasonable, gooey substance that is normally delivered by your body. Its biggest measures are found in you

Cart Summary